171 related articles for article (PubMed ID: 35122531)
1. Symptom science research conducted in community programs funded by the US National Cancer Institute: a 12-year review, 2008 to 2019.
Germain DS; Stevens WM; O'Mara A
Support Care Cancer; 2022 Jun; 30(6):4739-4746. PubMed ID: 35122531
[TBL] [Abstract][Full Text] [Related]
2. The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.
Denicoff AM; McCaskill-Stevens W; Grubbs SS; Bruinooge SS; Comis RL; Devine P; Dilts DM; Duff ME; Ford JG; Joffe S; Schapira L; Weinfurt KP; Michaels M; Raghavan D; Richmond ES; Zon R; Albrecht TL; Bookman MA; Dowlati A; Enos RA; Fouad MN; Good M; Hicks WJ; Loehrer PJ; Lyss AP; Wolff SN; Wujcik DM; Meropol NJ
J Oncol Pract; 2013 Nov; 9(6):267-76. PubMed ID: 24130252
[TBL] [Abstract][Full Text] [Related]
3. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
[TBL] [Abstract][Full Text] [Related]
4. Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program.
Buchanan DR; O'Mara AM; Kelaghan JW; Minasian LM
J Clin Oncol; 2005 Jan; 23(3):591-8. PubMed ID: 15659506
[TBL] [Abstract][Full Text] [Related]
5. Experience of the National Cancer Institute Community Cancer Centers Program on Community-Based Cancer Clinical Trials Activity.
Hirsch BR; Locke SC; Abernethy AP
J Oncol Pract; 2016 Apr; 12(4):e350-8. PubMed ID: 27026649
[TBL] [Abstract][Full Text] [Related]
6. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute-Designated Community Oncology Research Programs.
Dickens DS; Roth ME; Pollock BH; Langevin AM
JCO Oncol Pract; 2020 Oct; 16(10):e1060-e1066. PubMed ID: 32396490
[TBL] [Abstract][Full Text] [Related]
8. The NCI Community Oncology Research Program: what every clinician needs to know.
McCaskill-Stevens W; Lyss AP; Good M; Marsland T; Lilenbaum R
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714464
[TBL] [Abstract][Full Text] [Related]
9. Insights From Building a New National Cancer Institute Community Oncology Research Program Site.
Saphner T; Thompson MA; Planton S; Singh M; Glandt N; Robinson L; DeBartolo J
WMJ; 2016 Aug; 115(4):191-5. PubMed ID: 29099156
[TBL] [Abstract][Full Text] [Related]
10. Enrolling Older Adults Onto National Cancer Institute-Funded Clinical Trials in Community Oncology Clinics: Barriers and Solutions.
Hopkins JO; Braun-Inglis C; Guidice S; Wells M; Moorthi K; Berenberg J; St Germain D; Mohile S; Hudson MF
J Natl Cancer Inst Monogr; 2022 Dec; 2022(60):117-124. PubMed ID: 36519815
[TBL] [Abstract][Full Text] [Related]
11. Organizational and physician factors associated with patient enrollment in cancer clinical trials.
Jacobs SR; Weiner BJ; Reeve BB; Weinberger M; Minasian LM; Good MJ
Clin Trials; 2014 Oct; 11(5):565-75. PubMed ID: 24902923
[TBL] [Abstract][Full Text] [Related]
12. Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program.
Carpenter WR; Fortune-Greeley AK; Zullig LL; Lee SY; Weiner BJ
Contemp Clin Trials; 2012 Jan; 33(1):46-54. PubMed ID: 21986391
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of a Centralized Clinical Trials Coverage Analysis: A Joint Initiative of the American Society of Clinical Oncology and the National Cancer Institute.
Szczepanek CM; Hurley P; Good MJ; Denicoff A; Willenberg K; Dawson C; Kurbegov D
J Oncol Pract; 2017 Jun; 13(6):395-400. PubMed ID: 28481681
[TBL] [Abstract][Full Text] [Related]
14. The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps.
Zia FZ; Olaku O; Bao T; Berger A; Deng G; Fan AY; Garcia MK; Herman PM; Kaptchuk TJ; Ladas EJ; Langevin HM; Lao L; Lu W; Napadow V; Niemtzow RC; Vickers AJ; Shelley Wang X; Witt CM; Mao JJ
J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140486
[TBL] [Abstract][Full Text] [Related]
15. Reporting of health-related quality of life endpoints in National Cancer Institute-supported cancer treatment trials.
St Germain D; Denicoff A; Torres A; Kelaghan J; McCaskill-Stevens W; Mishkin G; O'Mara A; Minasian LM
Cancer; 2020 Jun; 126(11):2687-2693. PubMed ID: 32237256
[TBL] [Abstract][Full Text] [Related]
16. Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment.
Zaren HA; Nair S; Go RS; Enos RA; Lanier KS; Thompson MA; Zhao J; Fleming DL; Leighton JC; Gribbin TE; Bryant DM; Carrigan A; Corpening JC; Csapo KA; Dimond EP; Ellison C; Gonzalez MM; Harr JL; Wilkinson K; Denicoff AM
J Oncol Pract; 2013 Mar; 9(2):e55-61. PubMed ID: 23814525
[TBL] [Abstract][Full Text] [Related]
17. What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report.
Bertagnolli MM; Blanke CD; Curran WJ; Hawkins DS; Mannel RS; O'Dwyer PJ; Schnall MD; Wolmark N
Cancer; 2020 Dec; 126(23):5022-5029. PubMed ID: 32970346
[TBL] [Abstract][Full Text] [Related]
18. Children's Oncology Group 2023 blueprint for research: Cancer care delivery research.
Parsons SK; Beauchemin MP; Dupuis L; Sugalski A; Wolfson JA; Santacroce SJ; Marchak JG; Sung L; Roth ME;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30579. PubMed ID: 37469004
[TBL] [Abstract][Full Text] [Related]
19. Enrollment of adolescent and young adult patients newly diagnosed with cancer in NCI CTEP-sponsored clinical trials before and after launch of the NCI National Clinical Trials Network.
Sankaran H; Finnigan SR; McShane LM; Best AF; Seibel NL
Cancer; 2022 Nov; 128(21):3843-3849. PubMed ID: 36089859
[TBL] [Abstract][Full Text] [Related]
20. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
